J. Stern & Co. LLP Abbott Laboratories Transaction History
J. Stern & Co. LLP
- $1.06 Trillion
- Q4 2024
A detailed history of J. Stern & Co. LLP transactions in Abbott Laboratories stock. As of the latest transaction made, J. Stern & Co. LLP holds 315,433 shares of ABT stock, worth $42.8 Million. This represents 3.36% of its overall portfolio holdings.
Number of Shares
315,433
Previous 299,133
5.45%
Holding current value
$42.8 Million
Previous $34.1 Billion
4.62%
% of portfolio
3.36%
Previous 3.63%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,363Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.5 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.23 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.35 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $238B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...